Summary
India's first dengue vaccine, Qdenga, has arrived with a crucial safety caveat: it could enhance dengue in children who have not had a prior infection. In such cases, the vaccine might simulate a primary infection, offering protection against DENV-1 and DENV-2 but not DENV-3.